Evidence map›Paper›PMID 39766087›Full record

ArticleCancers2024

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study.

Anne de Bruijn, Robert-Jan Schipper, Adri C Voogd, Marleen J J Pullens, Johanne G Bloemen, Linda de Munck, Yvonne E van Riet, Sabine Siesling, Birgit E P Vriens, Grard A P Nieuwenhuijzen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anne de BruijnDepartment of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
Robert-Jan SchipperDepartment of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.ORCID 0000-0001-7211-5059
Adri C VoogdDepartment of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.
Marleen J J PullensMaster Advanced Nursing Practice, Faculty of People and Health, Fontys University of Applied Sciences, 5022 DM Tilburg, The Netherlands.
Johanne G BloemenDepartment of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
Linda de MunckDepartment of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.
Yvonne E van RietDepartment of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
Sabine SieslingDepartment of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 LC Utrecht, The Netherlands.ORCID 0000-0002-0273-824X
Birgit E P VriensDepartment of Internal Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.ORCID 0000-0002-6782-6291
Grard A P NieuwenhuijzenDepartment of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

elderly patientsHER2-positive breast cancerneoadjuvant endocrine therapyneo-adjuvant targeted therapy

Identifiers

PMID39766087
PMCPMC11674293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.